Stocks and Investing Stocks and Investing
Mon, May 6, 2019
Fri, May 3, 2019
Thu, May 2, 2019

Do Kim Maintained (ALNY) at Buy with Increased Target to $128 on, May 2nd, 2019


Published on 2024-10-26 13:31:41 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $126 to $128 on, May 2nd, 2019.

Do has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 2 agree with Do's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $70 on, Tuesday, April 9th, 2019
  • Esther Rajavelu of "UBS" Initiated at Hold on, Wednesday, January 23rd, 2019


These are the ratings of the 3 analyists that currently disagree with Do


  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $138 on, Monday, April 15th, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $116 on, Monday, April 15th, 2019
  • David Lebovitz of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, March 5th, 2019
Contributing Sources